Evaluation of Lipid-polyethylenimine Conjugates as Biocompatible Carriers of CpG Oligodeoxynucleotides to Macrophages

다국어 초록 (Multilingual Abstract)

Considering the potent immune stimulation by CpG oligodeoxynucleotides (CpGs), the development of CpG carriers is a prerequisite for efficient cancer immunotherapy.
In this study, we conjugated 1,2-distearoyl-sn-glycero-3- phosphoethanolamine-N-[hydroxyl succinimidyl (polyethylene glycol)] (DSPE-PEG-NHS) with polyethylenimine (PEI) to develop a PEI-PEG-DSPE conjugate that can serve as a biocompatible and efficient CpG carrier. Five types of PEIPEG- DSPE conjugates were developed, each with different molecular weights of PEI and different degrees of DSPEPEG modification, and all exhibited significantly lower cytotoxicity. In particular, compared to CpG delivery via natural PEI, delivery with PEI (25 kDa)-PEG-DSPE and DSPE-PEG-NHS/(amine groups of PEI) at a molar ratio of 0.1 resulted in a higher uptake of CpGs into RAW264.7 cells, probably because of the presence of a hydrophobic lipid moiety. In addition, PEI-PEG-DSPE/CpG complexes triggered significant cytokine secretion (TNF-α) from RAW264.7 cells, comparable to that triggered by PEI/CpG complexes. Thus, PEI-PEG-DSPE conjugates could serve as biocompatible and efficient carriers of the immune stimulator CpG to the macrophages.

참고문헌 (Reference)

1 Vancha, A. R, "Use of polyethyleneimine polymer in cell culture as attachment factor and lipofection enhancer" 4 : 23-, 2004

2 Josephs, S. F, "Unleashing endogenous TNF-alpha as a cancer immunotherapeutic" 16 : 242-, 2018

3 Forcato, D. O, "Transfection of bovine fetal fibroblast with polyethylenimine (PEI) nanoparticles:effect of particle size and presence of fetal bovine serum on transgene delivery and cytotoxicity" 69 : 655-665, 2017

4 Florea, B. I, "Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures" 4 : E12-, 2002

5 Wang, J, "The 40 kDa linear polyethylenimine inhibits porcine reproductive and respiratory syndrome virus infection by blocking its attachment to permissive cells" 11 : 876-, 2019

6 Reilley, M. J, "TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma" 7 : 323-, 2019

7 Bajaj, A, "Synthesis and gene transfection efficacies of PEI-cholesterol-based lipopolymers" 19 : 1640-1651, 2008

8 Hanagata, N, "Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system" 7 : 2181-2195, 2012

9 Rattanakiat, S, "Selfassembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulation" 47 : 352-358, 2012

10 Ozcan, G, "Preclinical and clinical development of siRNAbased therapeutics" 87 : 108-119, 2015

11 Cheng, T, "Polyethyleniminemediated CpG oligodeoxynucleotide delivery stimulates bifurcated cytokine induction" 4 : 1013-1018, 2018

12 Pandey, A. P, "Polyethylenimine: A versatile, multifunctional non-viral vector for nucleic acid delivery" 68 : 904-918, 2016

13 Wang, M., "Poly(ester amine) constructed from polyethylenimine and pluronic for gene delivery in vitro and in vivo" 23 : 3224-3233, 2016

14 Navarro, G, "Phospholipid-polyethylenimine conjugatebased micelle-like nanoparticles for siRNA delivery" 1 : 25-33, 2011

15 Navarro, G, "P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells" 7 : 65-78, 2012

16 김승훈, "Optimally Fabricated Chitosan Particles Containing Ovalbumin Induced Cellular and Humoral Immunity in Immunized Mice" 한국생물공학회 25 (25): 681-689, 2020

17 Hsu, C. Y. M, "Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression" 20 : 301-328, 2012

18 Buss, C. G, "Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics" 117 : 13428-13436, 2020

19 Zhang, H, "Nanodelivery systems for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides" 70 : 935-946, 2017

20 Ngamcherdtrakul, W, "Lyophilization and stability of antibodyconjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery" 13 : 4015-4027, 2018

21 Zhao, M, "Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA" 23 : 2596-2607, 2016

22 Wang, J, "In-vitro and in-vivo difference in gene delivery by lithocholic acidpolyethyleneimine conjugate" 217 : 119296-, 2019

23 Dube, B, "Hydrophobically modified polyethylenimine-based ternary complexes for targeting brain tumor: stability, in vitro and in vivo studies" 45 : 1685-1698, 2017

24 Liu, Z, "Hydrophobic modifications of cationic polymers for gene delivery" 35 : 1144-1162, 2010

25 김하늘, "Exosome-mediated Let7c-5p Delivery for Breast Cancer Therapeutic Development" 한국생물공학회 25 (25): 513-520, 2020

26 배춘식, "Encapsulation of Apoptotic Proteins in Lipid Nanoparticles to Induce Death of Cancer Cells" 한국생물공학회 25 (25): 264-271, 2020

27 Chen, H. C, "Effects of particle size on toll-like receptor 9-mediated cytokine profiles" 32 : 1731-1737, 2011

28 전수환, "Effective Delivery of siRNA to Transgenic Rice Cells for Enhanced Transfection Using PEI-based Polyplexes" 한국생물공학회 22 (22): 577-585, 2017

29 Yang, S, "Delivery of antisense oligonucleotide using polyethylenimine-based lipid nanoparticle modified with cell penetrating peptide" 26 : 965-974, 2019

30 Kafil, V, "Cytotoxic impacts of linear and branched polyethylenimine nanostructures in a431 cells" 1 : 23-30, 2011

31 Shirota, H, "CpG oligonucleotides as cancer vaccine adjuvants" 3 : 390-407, 2015

32 Hanagata, N, "CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies" 12 : 515-531, 2017

33 Jung, H, "CpG incorporated DNA microparticles for elevated immune stimulation for antigen presenting cells" 8 : 6608-6615, 2018

34 장효은, "Cleavable conjugation of CpG oligodeoxynucleotides onto microparticles for facile release and cytokine induction in macrophages" 한국응용생명화학회 60 (60): 321-326, 2017

35 Bordelon, H, "Characterization of plasmid DNA location within chitosan/PLGA/pDNA nanoparticle complexes designed for gene delivery" 2011 : 952060-, 2011

36 Hong, J, "Cardiac RNAi therapy using RAGE siRNA/deoxycholic acid-modified polyethylenimine complexes for myocardial infarction" 35 : 7562-7573, 2014

37 Chuang, Y. C, "Adjuvant effect of toll-like receptor 9 activation on cancer immunotherapy using checkpoint blockade" 11 : 1075-, 2020

38 Moghimi, S. M, "A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy" 11 : 990-995, 2005

39 Hemmi, H, "A toll-like receptor recognizes bacterial DNA" 408 : 740-745, 2000